Nephrology And Urology Devices Global Market Report 2018 Including: Dialysis Devices; Endoscopy Devices; Benign prostatic hyperplasia (BPH) Treatment Devices; Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices; Urinary Stone Treatment Devices Covering: Baxter International Inc., Fresenius Medical Care AG & Co. KGAA, Cook Group Incorporated, B. Braun Group, C. R. Bard Inc.
Feb 2018
Reasons to Purchase • Outperform competitors using accurate up to date demand-side dynamics information. • Identify growth segments for investment. • Facilitate decision making on the basis of historic and forecast data and the drivers and restraints on the market. • Create regional and country strategies on the basis of local data and analysis. • Stay abreast of the latest customer and market research findings • Benchmark performance against key competitors. • Develop strategies based on likely future developments. • Utilize the relationships between key data sets for superior strategizing. • Suitable for supporting your internal and external presentations with reliable high quality data and analysis • Gain a global perspective on the development of the market. • Report will be updated with the latest data and delivered to you within 3-5 working days of order.
Scope Markets Covered: Dialysis Devices; Endoscopy Devices; Benign prostatic hyperplasia (BPH) Treatment Devices; Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices; Urinary Stone Treatment Devices Companies Mentioned: Baxter International Inc., Fresenius Medical Care AG & Co. KGAA, Cook Group Incorporated, B. Braun Group, C. R. Bard Inc. Countries: Brazil, China, France, Germany, India, Italy, Japan, Spain, Russia, UK, USA and Australia. Regions: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East And Africa. Time series: Five years historic and forecast. Data: Ratios of market size and growth to related markets, GDP, Expenditure Per Capita, Nephrology And Urology Devices Indicators Comparison. Data segmentations: Country and regional historic and forecast data, market share of competitors, market segments. Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Nephrology And Urology Devices Market Characteristics Nephrology and urology devices are used in the treatment and diagnosis of diseases related to kidney (Nephrology) and genitourinary system including urinary tract systems of both genders and male reproductive system problems (Urology). Most commonly occur diseases related to those systems are chronic kidney diseases (CKD), kidney stones, end stage renal disease (ESRD), urinary incontinence, pelvic organ prolapse and benign prostatic hyperplasia (BPH). Nephrology and urology devices market in this report is segmented into dialysis devices, urinary stone devices, incontinence & pelvic organ prolapse devices, benign prostatic hyperplasia treatment devices, endoscopy devices. Dialysis Devices are used in  Hemodialysis Devices are used in  Peritoneal Dialysis Devices are used in Urinary Stone Devices are used in the treatment and Incontinence & Pelvic Organ Prolapse Devices are used in the Benign Prostatic Hyperplasia (BPH) Treatment Devices are used in the Endoscopy Devices are used to diagnose the diseases or In this report market value is defined as the revenues organizations earn by selling their goods and services within the specified market, based on the price at which they sell. Only goods and services traded between entities are included. The revenues for a specified geography are consumption values – that is, they are revenues generated by organizations in the specified geography within the specified market, irrespective of where they are produced.
Nephrology And Urology Devices Market Historic Growth The global nephrology and urology devices market grew from $X billion in 2013 to $X billion in 2017 at a compound annual growth rate (CAGR) of X%. The chart and table below shows the year-on-year growth of the global nephrology and urology devices market during 2013 – 2017.
Drivers of the Market:
Restraints on the Market:
Nephrology And Urology Devices Market Forecast Growth The global nephrology and urology devices market is expected to grow from $XX billion in 2017 to $23.1 billion in 2021 at a compound annual growth rate (CAGR) of XX%. The chart and table below shows the year-on-year growth of the global nephrology and urology devices market during 2017 - 2021.
Drivers of the Market:
Restraints on the Market:
Nephrology And Urology Devices Market Segmentation The chart and table below shows the split of the nephrology and urology devices market in 2017.
The total market value for nephrology and urology devices was $X billion in 2017. The markets that are covered include Dialysis Devices; Endoscopy Devices; Benign prostatic hyperplasia (BPH) Treatment Devices; Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices; Urinary Stone Treatment Devices. Dialysis Devices was the X largest segment in the nephrology and urology devices market with X% share of the market. The market value for the dialysis devices was $X billion in 2017. Endoscopy devices made up around X% share of the market. The market value for the endoscopy devices was $X billion in 2017.
Nephrology And Urology Devices Market Regional And Country Analysis The Asia Pacific was the largest region in the nephrology and urology devices market in 2017, nephrology and urology devices for $X billion or X% market share. North America was the x largest region nephrology and urology devices for $X billion or X% market share. Western Europe was the x largest region nephrology and urology devices for $X billion or X% market share.
Nephrology And Urology Devices Market Competitive Landscape The leading competitors in the global nephrology and urology devices market are Baxter International Inc., Fresenius Medical Care AG & Co. KGAA, Cook Group Incorporated, B. Braun Group, C. R. Bard Inc. The chart and table below displays the percentage market share of the top players in the nephrology and urology devices market industry.
Baxter International Inc. generated revenues of $XX billion for the financial year 2016, an XX% increase from the previous year. Fresenius Medical Care AG & Co KGaA generated revenues of $XX billion for the financial year 2016, an XX% increase from the previous year. B. Braun Group generated revenues of $XX billion for the financial year 2016, an XX% increase from the previous year. C. R. Bard Inc. generated revenues of $XX billion for the financial year 2016, an XX% increase from the previous year.
Nxstage Medical Inc. generated revenues of $XX billion for the financial year 2016, an XX% increase from the previous year. Dornier MedTech Systems GmbH generated revenues of $XX billion for the financial year 2016, an XX% increase from the previous year. Cook Group Incorporated generated revenues of $XX billion for the financial year 2015. Company Profile Baxter International Inc. Overview Baxter International Inc. was the X largest company in the nephrology and urology devices market with XX% share of the market. Baxter is primarily engaged in the manufacture and distribution of products to treat immune disorders, kidney diseases, hemophilia and other chronic and acute medical conditions. Baxter has manufacturing facilities in 27 countries worldwide and employs around 50,000 people. Products and Services Baxter International operates through the following segments: The Hospital Products segment The Renal Products segment provides Strategy Baxter International’s growth strategy is to improve its product offerings by investing in research and Financial Performance Baxter International Inc. earned a revenue of $XX billion from renal division in 2016, a XX% increase from the previous year. It had a market
Fresenius Medical Care AG & Co. KGAA Overview Products and Services Strategy Financial Performance Cook Group Incorporated Overview Products and Services Strategy Financial Performance B. Braun Group Overview Products and Services Strategy Financial Performance C. R. Bard Inc. Overview Products and Services Strategy Financial Performance